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background:  Several studies, including a genome-wide association study in 2012, have confirmed that an aldehyde dehydrogenase 2 (ALDH2) 
rs671 polymorphism, resulting in a Glu504Lys replacement that eliminates ALDH2 activity in both heterozygotes and mutation homozygotes by 1%-
6%, is a susceptibility gene for coronary atherosclerotic disease. In this study, we hypothesized that expression of ALDH2 may affect plaque stability 
via inflammation.
methods:  Sixty male apo E-deficient mice treated with a high fat diet and with a constrictive collar placed around the right common carotid 
artery for 8 weeks were divided randomly into three groups: the lentivirus (Lv)-green fluorescent protein (GFP) group, the ALDH2 overexpression and 
RNAi groups (n = 20 each). Tissue samples from the right carotid arteries were stained to calculate the plaque vulnerability index and inflammatory 
response. Human umbilical vein endothelial cell culture was performed to assess the expression of inflammation factors and signaling pathway 
molecules after interference with Lv-ALDH2.
results:  Four weeks after ALDH2 gene transfer, the vulnerability index in the ALDH2 overexpression group decreased, but the index in the RNAi 
group increased markedly compared with that of the GFP group. Compared with the results of the GFP group, the expression of inflammation factors 
such as interleukin 6, matrix metalloproteinase 2, intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 were reduced in the 
overexpression group and increased in the RNAi group. In vitro experiments demonstrated that ALDH2 influenced inflammatory molecules through 
some members of the mitogen-activated protein kinases (MAPK) families (Jun-N terminal kinase and p38-MAPK) and then nuclear factor-κB and 
activator protein 1 signaling pathways.
Conclusions:  ALDH2 with different activities significantly influences plaque vulnerability through the inflammatory response via the MAPK, nuclear 
factor-κB and activator protein 1 signaling pathways. The findings provide a novel preventive and therapeutic strategy for cardiovascular diseases, 
especially in East Asians, among whom 30%-50% possess the inactive ALDH2 mutant allele.
